Latest news
Pfizer's Vitiligo Pill Shows Promise as Doctors Explain Why the Condition Is More Than Skin Deep - Medical DailyMedical Daily · Tue, 04 Aug 2026 15:30:09 GMTPhase III Trials Show Positive Results for Ritlecitinib in Nonsegmental Vitiligo - Medical DialoguesMedical Dialogues · Sun, 02 Aug 2026 23:30:18 GMTPfizer’s LITFULO clears two Phase 3 vitiligo trials paving way for global regulatory filings - Indian Pharma PostIndian Pharma Post · Sat, 01 Aug 2026 14:24:34 GMTAbbVie’s Rinvoq approved by European Commission for non-segmental vitiligo - PMLiVEPMLiVE · Fri, 31 Jul 2026 11:41:32 GMTThermo Fisher Launches Real-World Registry to Advance Long-Term Vitiligo Research - BioPharma APACBioPharma APAC · Fri, 31 Jul 2026 00:43:03 GMTPfizer's ritlecitinib advances to become first oral systemic therapy for nonsegmental vitiligo - AllSciAllSci · Thu, 30 Jul 2026 16:35:55 GMTRitlecitinib Meets Co-Primary End Points in Phase 3 Nonsegmental Vitiligo Trials - Dermatology TimesDermatology Times · Thu, 30 Jul 2026 13:32:39 GMTRitlecitinib Improves Repigmentation in Nonsegmental Vitiligo Phase 3 Data - HCPLiveHCPLive · Thu, 30 Jul 2026 13:27:25 GMT